Published :
Report ID:
Pages :
Format :
The global Poultry Drugs Market size is projected to grow at a CAGR of 10% during the forecast period from 2022 - 2030.
Poultry Drugs Market Overview:
Poultry drugs consist of vaccines, feed additive medicines, medicines such as anthelmintics, and specialty products used for reproduction, metabolism or infectious disease control.
Poultry Drugs market size estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Poultry Drugs market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and other global crisis.
Significant Poultry Drugs Market Dynamics and Growth Factors:
Drivers
Increasing consumption of chicken meat is expected to propel the growth of the global poultry drugs market over the forecast period. For example, a study presented at the 2018 Chicken Marketing Summit in Florida found that 86% of consumers surveyed in the United States over a two-week period ate chicken meal or snacks purchased from a supermarket and 68% from a restaurant.
Additionally, significant growth in the poultry segment is also expected to aid the market growth. For example, according to the 2019 American Poultry and Eggs Association, National Chicken Association, National Federation of Turkey Federation and United Egg Producers Report, the poultry sector generated $495.1 billion in economic activity and $38.5 billion in government revenue.
Restraints
Low product exclusivity, generic competition and stringent regulations are expected to hamper the growth of the global poultry drugs market. The product exclusivity period is only 3 to 5 years in the animal drug industry. Shorter exclusivity periods intensify competition from generic and over-the-counter (OTC) products. In addition, stringent regulations for product approval and limited vaccine production hamper the market growth.
In addition, growing concerns about the use of antibiotics and growth promoters in poultry are expected to limit the market growth. Growth promoters include hormonal components and antibiotics widely used in food or meat producing animals such as poultry animals. There is strong evidence of negative effects of poultry antibiotics on humans, such as the induction of antimicrobial-resistant bacteria and disruption of the normal human gut flora.
The Poultry Drugs market research report is categorized based on type, applications and region.
Market Key Players:
Zoetis, Merck, Virbac, Boehringer Ingelheim, Elanco, Bayer Animal Health, Phibro Animal Health, Zydus, Ceva, and others.
By Type:
By Application:
By Region:
Geographically, the global Poultry Drugs market has been analysed in various regions such as North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA).
The poultry drugs market in North America is expected to grow over the forecast period of 2021-2030. Growth in major poultry producing countries such as Mexico and Canada, rising production rates in various regions owing to rising demand for meat products are factors that propel the growth of this industry. In Latin America, the poultry drugs market is expected to grow at a significant rate during the forecast period. Growing population in the region has increased the demand for animal protein, which has further boosted the growth of agriculture-based industries including poultry breeding. As a result, veterinary drugs are increasingly being used by farmers to ensure healthier and more productive poultry. Europe is one of the leading poultry producers and accounts for a significant share of total world production. The European Union (EU) has been one of the largest markets for veterinary medicines used in animal husbandry, including carnivores, dairy cattle and farmed species such as fish. The Asia-Pacific poultry drugs market size is expected to grow. Increasing poultry population combined with changing consumer preferences, increasing demand for convenience foods, and increasing standardization are some of the major factors driving the growth of this market. Additionally, high prevalence of food-borne diseases in humans due to chicken consumption is another factor driving the market.
Further the regions are divided into countries as follows
Poultry Drugs Market report scope
Report Attributes |
Details |
Growth Rate |
CAGR of 10% during the forecast period. |
By Type |
Parasiticides, Antibiotics, Anti-inflammatory Drugs |
By Application |
Turkey, Chicken, Goose, Duck |
By Companies |
Zoetis, Merck, Virbac, Boehringer Ingelheim, Elanco, Bayer Animal Health, Phibro Animal Health, Zydus, Ceva |
Regions and Countries Covered |
|
Base Year |
2022 |
Historical Year |
2017 to 2022 |
Forecast Year |
2023 to 2030 |
Industry News
Key Takeaways from this Poultry Drugs Report
Frequently Asked Questions
At what CAGR is the Poultry Drugs market projected to grow in the forecast period 2022 to 2030?
What are the types of Poultry Drugs market?
What are the applications of Poultry Drugs market?
Who are the top players in Poultry Drugs market?
Which application segment is expected to drive the growth of the Poultry Drugs market in the next 5 years?
Which are the key deployments types adopting Poultry Drugs market?